Cargando…

DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia

OBJECTIVE: Intestinal metaplasia (IM) is a premalignant stage that poses a greater risk for subsequent gastric cancer (GC). However, factors regulating IM to GC progression remain unclear. Previously, activated DNA damage response (DDR) signalling factors were shown to engage tumour-suppressive netw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krishnan, Vaidehi, Lim, Debbie Xiu En, Hoang, Phuong Mai, Srivastava, Supriya, Matsuo, Junichi, Huang, Kie Kyon, Zhu, Feng, Ho, Khek Yu, So, Jimmy Bok Yan, Khor, Christopher, Tsao, Stephen, Teh, Ming, Fock, Kwong Ming, Ang, Tiing Leong, Jeyasekharan, Anand D, Tan, Patrick, Yeoh, Khay-Guan, Ito, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Stomach
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497583/ https://www.ncbi.nlm.nih.gov/pubmed/31937549 http://dx.doi.org/10.1136/gutjnl-2019-319002

Ejemplares similares

Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP)
por: Lee, Jonathan W J, et al.
Publicado: (2022)

Iqgap3-Ras axis drives stem cell proliferation in the stomach corpus during homoeostasis and repair
por: Matsuo, Junichi, et al.
Publicado: (2021)

Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
por: So, Jimmy Bok Yan, et al.
Publicado: (2021)

CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype
por: Barros, Rita, et al.
Publicado: (2010)

Chief cell plasticity is the origin of metaplasia following acute injury in the stomach mucosa
por: Caldwell, Brianna, et al.
Publicado: (2022)

MicroRNA-92a-1–5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia
por: Li, Ting, et al.
Publicado: (2019)

Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication
por: Sung, Joseph J Y, et al.
Publicado: (2020)

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
por: Sundar, Raghav, et al.
Publicado: (2022)

Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach
por: Bockerstett, Kevin A, et al.
Publicado: (2020)

Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
por: Lin, Suling J, et al.
Publicado: (2015)

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
por: Deng, Niantao, et al.
Publicado: (2012)

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial
por: Sundar, Raghav, et al.
Publicado: (2022)

Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands
por: Chiang, Tsung-Hsien, et al.
Publicado: (2021)

Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
por: Fang, Yu-Jen, et al.
Publicado: (2015)

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding
por: Scholtz, Samantha, et al.
Publicado: (2014)

POU2F2-oriented network promotes human gastric cancer metastasis
por: Wang, Si-Meng, et al.
Publicado: (2016)

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
por: Wang, Ting-ting, et al.
Publicado: (2017)

Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies
por: Wang, Zhaoming, et al.
Publicado: (2017)

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers
por: Laine, Loren, et al.
Publicado: (2012)

Prescription of and Adherence to Non-Steroidal Anti-Inflammatory Drugs and Gastroprotective Agents in At-Risk Gastrointestinal Patients
por: Lanas, Angel, et al.
Publicado: (2012)

Competing Influences in the Management of Gastrointestinal Bleeding
por: Sonnenberg, Amnon
Publicado: (2012)

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori
por: Basu, P Patrick, et al.
Publicado: (2011)

GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial
por: Cryer, Byron, et al.
Publicado: (2013)

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
por: Filion, Kristian B, et al.
Publicado: (2014)

HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
por: Chang, Hae Ryung, et al.
Publicado: (2016)

Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study
por: Asada, Kiyoshi, et al.
Publicado: (2015)

OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer
por: Qian, Jin, et al.
Publicado: (2015)

MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome
por: Wang, Kunning, et al.
Publicado: (2016)

Impairment of Salivary Mucin Production Resulting in Declined Salivary Viscosity During Naproxen Administration as a Potential Link to Upper Alimentary Tract Mucosal Injury
por: Garcia, Cesar J, et al.
Publicado: (2013)

Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
por: Ferreira, Rui M, et al.
Publicado: (2018)

Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD)
por: Taylor, Fiona, et al.
Publicado: (2018)

Mucosal microbiome dysbiosis in gastric carcinogenesis
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2018)

Human gastric cancer modelling using organoids
por: Seidlitz, Therese, et al.
Publicado: (2019)

Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study
por: Cai, Quancai, et al.
Publicado: (2019)

Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection
por: Boccellato, Francesco, et al.
Publicado: (2019)

Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles
por: Erawijantari, Pande Putu, et al.
Publicado: (2020)

MiR130b from Schlafen4(+) MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer
por: Ding, Lin, et al.
Publicado: (2020)

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
por: Wang, Ruiping, et al.
Publicado: (2020)

Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis
por: Wang, Pin, et al.
Publicado: (2019)

Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing
por: Zhang, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ktaeh4ojm70io4u8vbmoguq904